Tailored therapy for heart failure: the role of biomarkers

被引:5
|
作者
Wollert, Kai C. [1 ]
机构
[1] Hannover Med Sch, Dept Cardiol & Angiol, Div Mol & Translat Cardiol, D-30625 Hannover, Germany
关键词
GALECTIN-3; TRIAL; ROSUVASTATIN;
D O I
10.1093/eurheartj/ehs129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2246 / 2248
页数:3
相关论文
共 50 条
  • [1] Tailored therapy for heart failure: neurohormones
    Richards, A. Mark
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2011, 89 (08) : 603 - 607
  • [2] Tailored therapy to hemodynamic goals for advanced heart failure
    Stevenson, LW
    EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) : 251 - 257
  • [3] Using Biomarkers to Guide Heart Failure Therapy
    Jaffe, Allan S.
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY, 2017, 63 (05) : 954 - 957
  • [4] Effects of ivabradine therapy on heart failure biomarkers
    Ordu, Serkan
    Yildiz, Bekir Serhat
    Alihanoglu, Yusuf Izzettin
    Ozsoy, Aybars
    Tosun, Mehmet
    Evrengul, Harun
    Kaftan, Havane Asuman
    Ozhan, Hakan
    CARDIOLOGY JOURNAL, 2015, 22 (05) : 501 - 509
  • [5] Hemodynamically tailored therapy in congestive heart failure: Alive and well
    Nagueh, Sherif F.
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (08) : 626 - 628
  • [6] Tailored therapy using dobutamine and nitroglycerin in advanced heart failure
    Drazner, MH
    Solomon, MA
    Thompson, B
    Yancy, CW
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (08): : 941 - +
  • [7] Use of biomarkers to guide outpatient therapy of heart failure
    DeBeradinis, Benedetta
    Januzzi, James L., Jr.
    CURRENT OPINION IN CARDIOLOGY, 2012, 27 (06) : 661 - 668
  • [8] The role of race in heart failure therapy
    Yancy C.W.
    Current Cardiology Reports, 2002, 4 (3) : 218 - 225
  • [9] The role of statins in therapy of heart failure
    Rozentryt, Piotr
    Nowak, Jolanta
    Polonski, Lech
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2007, 4 (03): : 290 - 299
  • [10] The Role of Antithrombotic Therapy in Heart Failure
    Chrysohoou, Christina
    Magkas, Nikolaos
    Antoniou, Christos-Konstantinos
    Manolakou, Panagiota
    Laina, Aggeliki
    Tousoulis, Dimitrios
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (23) : 2735 - 2761